HIGHLIGHTS
- who: mfi from the Heart Failure with Reduced Ejection Fraction (HFrEF) in Indonesia have published the Article: Indonesian Journal of Pharmacy, in the Journal: (JOURNAL)
- what: In the study , sacubitril/valsartan was compared with other ARB drugs since enalapril was not available yet in Indonesia. The study has limitations as other modeling analyses to deal with uncertainty that might lead to bias of the study results. This study provides an estimation of the impact of sacubitril/valsartan application in the treatment of patients with HF and reduced ejection fraction as input for Indonesia healthcare payer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.